UACR、KIM-1、IGF-1 水平与老年糖尿病肾病患者病情严重程度的关系*

彭扬洋 ,  孙玲君 ,  杨灿 ,  陈克岩

国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 577 -581.

PDF (1349KB)
国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 577 -581. DOI: 10.3969/j.issn.1674-7593.2026.06.012
论著

UACR、KIM-1、IGF-1 水平与老年糖尿病肾病患者病情严重程度的关系*

作者信息 +

The relationship between UACR, KIM-1, and IGF-1 levels and the severity of diabetic kidney disease in elderly patients

Author information +
文章历史 +
PDF (1380K)

摘要

目的 探讨尿白蛋白/ 肌酐比值 (UACR)、 肾损伤分子-1 (KIM-1)、 胰岛素样生长因子-1 (IGF-1) 水平与老年糖尿病肾病患者病情严重程度的关系。方法 回顾性收集南京医科大学第四附属医院 2023 年 8 月-2025 年 7 月收治的 200 例老年糖尿病患者的临床资料, 根据糖尿病肾病发生情况分为单纯性糖尿病组和糖尿病肾病组。 比较两组 UACR、KIM-1、IGF-1 水平, 分析各指标对老年糖尿病肾病的诊断效能。 评估老年糖尿病肾病患者病情严重程度, 比较不同病情严重程度的老年糖尿病肾病患者的 UACR、KIM-1、IGF-1 水平, 重点分析 UACR、KIM-1、IGF-1 与老年糖尿病肾病患者病情严重程度的相关性。结果 200 例老年糖尿病患者中患糖尿病肾病 74 例 (37%)。 糖尿病肾病组的病程、 空腹血糖 (FBG)、 糖化血红蛋白 (HbA1c)、 血肌酐 (Scr)、 血尿酸 (UA)、 血尿素 (UR)、UACR、KIM-1、IGF-1 水平均高于单纯性糖尿病组 (P < 0. 05); 经多元 logistic 回归分析显示, 病程、FBG、HbA1c、Scr、UA、UACR、KIM-1、IGF-1 升高是老年糖尿病肾病发生的危险因素 (P<0. 05); 绘制 ROC 曲线显示, UACR、 KIM-1、IGF-1 诊断老年糖尿病肾病的 AUC 均>0. 70, 均有诊断价值, 且各指标联合检测价值最高, AUC 为 0. 910; 大量白蛋白尿期老年糖尿病肾病患者 UACR、KIM-1、IGF-1 水平依次高于微量白蛋白尿期、 高滤过期患者 (P<0. 05); 经 Kendall􀆳s tau-b 相关系数检验显示, UACR、KIM-1、IGF-1 水平与老年糖尿病肾病患者病情严重程度均呈正相关 (P<0. 05)。结论 UACR、KIM-1、IGF-1 水平与老年糖尿病肾病患者病情严重程度显著相关, 且对疾病诊断有一定价值, 考虑未来可作为老年糖尿病肾病诊断、 病情严重程度评估的参考指标。

Abstract

Objective To investigate the relationship between urinary albumin-to-creatinine ratio (UACR), kidney injury molecule-1 (KIM-1), insulin-like growth factor-1 (IGF-1) levels and the severity of diabetic kidney disease in elderly patients. Methods Clinical data of 200 elderly diabetic patients admitted to the Fourth Affiliated Hospital of Nanjing Medical University from August 2023 to July 2025 were retrospectively collected. According to the occurrence of diabetic kidney disease, the patients were divided into a simple diabetes mellitus group and a diabetic kidney disease group. UACR, KIM-1, and IGF-1 levels were measured and compared between the two groups; the diagnostic value of each indicator for elderly diabetic kidney disease was analyzed, and the severity of diabetic kidney disease in elderly patients was assessed. UACR, KIM-1, and IGF-1 levels were compared among elderly diabetic kidney disease patients with different degrees of severity, with emphasis on analyzing the correlation between UACR, KIM-1, and IGF-1 levels and the severity of diabetic kidney disease in elderly patients. Results Among 200 elderly patients with diabetes mellitus, 74 cases were complicated with diabetic nephropathy, accounting for 37%. The disease course, fasting blood glucose (FBG), glycated hemoglobin A1c (HbA1c), serum creatinine (Scr), serum uric acid (UA), blood urea (UR), and levels of UACR, KIM-1, and IGF-1 in the diabetic kidney disease group were all higher than those in the simple diabetes mellitus group (P<0. 05). Multivariate logistic regression analysis showed that prolonged disease course and elevated FBG, HbA1c, Scr, UA, UACR, KIM-1, and IGF-1 were risk factors for elderly diabetic kidney disease (P < 0. 05). Receiver operating characteristic (ROC) curve analysis showed that the area under the curve (AUC) of UACR, KIM-1, and IGF-1 for diagnosing elderly diabetic kidney disease were all greater than 0. 70, indicating diagnostic value, with combined detection of the three indicators showing the highest diagnostic value (AUC = 0. 910). UACR, KIM-1, and IGF-1 levels in elderly diabetic kidney disease patients at the macroalbuminuria stage were successively higher than those in patients at the microalbuminuria stage and the hyperfiltration stage (P < 0. 05). Kendall􀆳s tau-b correlation coefficient test showed that UACR, KIM-1, and IGF-1 levels were all positively correlated with the severity of diabetic kidney disease in elderly patients (P< 0. 05). Conclusion UACR, KIM-1, and IGF-1 levels are significantly correlated with the severity of diabetic kidney disease in elderly patients and demonstrate certain diagnostic value; these indicators may therefore serve as reference markers for the diagnosis and severity assessment of elderly diabetic kidney disease in the future.

关键词

糖尿病肾病 / 尿白蛋白/ 肌酐比值 / 肾损伤分子-1 / 胰岛素样生长因子-1 / 相关性

Key words

Diabetic kidney disease / Urinary albumin-to-creatinine ratio / Kidney injury molecule-1 / Insulin-like growth factor-1 / Correlation

引用本文

引用格式 ▾
彭扬洋,孙玲君,杨灿,陈克岩. UACR、KIM-1、IGF-1 水平与老年糖尿病肾病患者病情严重程度的关系*[J]. 国际老年医学杂志, 2026, 47(6): 577-581 DOI:10.3969/j.issn.1674-7593.2026.06.012

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Rayego-Mateos S, Rodrigues-Diez R R, Fernandez-Fer-nandez B, et al. Targeting inflammation to treat diabetic kidney disease: the road to 2030[J]. Kidney Int, 2023, 103(2): 282-296.

[2]

Cleveland K H, Schnellmann R G . Pharmacological tar-geting of mitochondria in diabetic kidney disease [J]. Pharmacol Rev, 2023, 75(2): 250-262.

[3]

Scilletta S, Di Marco M, Miano N, et al. Update on dia-betic kidney disease (DKD): focus on non-albuminuric DKD and cardiovascular risk[J]. Biomolecules, 2023, 13(5): 752.

[4]

陈纤纤, 冯烈, 周颖, 等. 糖尿病肾病与其他类型肾病患者肾组织中 Smad1 蛋白表达的比较[J]. 基础医学与临床, 2023, 43(7): 1097-1103.

[5]

Chen X X, Feng L, Zhou Y, et al. Comparative analysis of Smad1 protein expression in renal tissue among patients with diabetic nephropathy versus other types of nephropa-thy[J]. Basic Clin Med, 2023, 43(7): 1097-1103.

[6]

Jin P, Ye S, Ye H, et al. Urinary microalbumin/ creati-nine ratio is a predictor of the occurrence and severity of leukoaraiosis[J]. Neuro Endocrinol Lett, 2023, 44(8): 528-536.

[7]

张文娟, 宋茜茜, 姚明言, 等. 洛塞那肽对早期 2 型糖尿病肾病治疗效果及对肾损伤分子-1、尿转铁蛋白影响[J]. 临床军医杂志, 2025, 53(6): 630-633.

[8]

Zhang W J, Song Q Q, Yao M Y, et al. Therapeutic effi-cacy of lorcaserin in the treatment of early type 2 diabetic nephropathy and its effect on kidney injury molecule-1 and urinary transferrin [J]. Clin J Med Off, 2025, 53 (6): 630-633.

[9]

任宇晴, 唐堂, 李颖, 等. 降糖丸抑制 TGF-β1 改善糖尿病肾病小鼠肾损伤及纤维化[J]. 中国药理学通报, 2023, 39(10): 1988-1993.

[10]

Ren Y Q, Tang T, Li Y, et al. Hypoglycemic pill inhib-its TGF-β1 to ameliorate renal injury and fibrosis in dia-betic nephropathy-induced mice [ J ]. Chin Pharmacol Bull, 2023, 39(10): 1988-1993.

[11]

李晓松, 刘美娜, 郝元涛, 等. 卫生统计学[M]. 第 8版. 北京: 人民卫生出版社, 2017: 64-68.

[12]

中华医学会糖尿病学分会, 国家基层糖尿病防治管理办公室. 国家基层糖尿病防治管理指南(2022) [J]. 中华内科杂志, 2022, 61(3): 249-262.

[13]

Chinese Diabetes Society, National Office for Primary Di-abetes Prevention and Management. National guidelines for primary care diabetes prevention and management (2022) [J]. Chin J Intern Med, 2022, 61 (3): 249-262.

[14]

中华医学会糖尿病学分会微血管并发症学组. 糖尿病肾病防治专家共识(2014 年版)[J]. 中华糖尿病杂志, 2014, 6(11): 792-801.

[15]

Microvascular Complications Working Group, Chinese Diabetes Society. Expert consensus on the prevention and ftreatment of diabetic nephropathy (2014 edition) [J]. Chin J Diabetes Mellitus, 2014, 6(11): 792-801.

[16]

中华医学会肾脏病学分会专家组. 糖尿病肾脏疾病临床诊疗中国指南[J]. 中华肾脏病杂志, 2021, 37 (3): 255-304.

[17]

Expert Panel of the Renal Disease Branch, Chinese Med-ical Association. Chinese guidelines for the clinical diag-nosis and treatment of diabetic kidney disease[J]. Chin J Nephrol, 2021, 37(3): 255-304.

[18]

Zhu L, Zhao J, Li Q . Clinical study on prescription used for invigorating spleen, reinforcing kidney and warming yang combined with calcium dobesilate in treatment of se-nile diabetic nephropathy [ J ]. Biotechnol Genet Eng Rev, 2024, 40(3): 1737-1747.

[19]

Lv Z, Hu J, Su H, et al. TRAIL induces podocyte PAN-optosis via death receptor 5 in diabetic kidney disease [J]. Kidney Int, 2025, 107(2): 317-331.

[20]

王耿, 孟利, 袁丽. 血清 Netrin-1、VEGF、VCAM-1 在 2型糖尿病肾病诊断中的应用[J]. 国际泌尿系统杂志, 2025, 45(6): 135-138.

[21]

Wang G, Meng L, Yuan L. Application of serum Netrin-1, VEGF, and VCAM-1 in the diagnosis of type 2 diabet-ic nephropathy[J]. Int J Urol Nephrol, 2025, 45(6): 135-138.

[22]

崔健, 夏青, 周茜宁. 尿白蛋白/ 肌酐比值与2 型糖尿病慢性并发症关系的研究进展[J]. 医学综述, 2023, 29(24): 5765-5768.

[23]

Cui J, Xia Q, Zhou Q N. Research progress on the rela-tionship between urinary albumin/ creatinine ratio and chronic complications of type 2 diabetes mellitus [J]. Med Recapitulate, 2023, 29(24): 5765-5768.

[24]

Mahemuti N, Zou J, Liu C, et al. Urinary albumin-to-creatinine ratio in normal range, cardiovascular health, and all-cause mortality[J]. JAMA Netw Open, 2023, 6 (12): e2348333.

[25]

孙小芳, 尹丽明, 包利文, 等. KIM1、TIMP2 及炎症指标与 2 型糖尿病肾病进展风险的相关性研究[J]. 海南医学, 2024, 35(14): 2036-2041.

[26]

Sun X F, Yin L M, Bao L W, et al. Correlation between KIM1, TIMP2, and inflammatory markers with the risk of progression to type 2 diabetic nephropathy[J]. Hainan Med J, 2024, 35(14): 2036-2041.

[27]

李坤, 赵维丽, 张培, 等. 糖尿病早期肾损伤诊断中生化指标联合肾损伤分子-1 的临床价值评价[J]. 中华保健医学杂志, 2024, 26(5): 697-698, 701.

[28]

Li K, Zhao W L, Zhang P, et al. Clinical value evalua-tion of the combined use of biochemical markers and kid-ney injury molecule-1 in the diagnosis of early diabetic kidney injury [J]. Chin J Health Care Med, 2024, 26 (5): 697-698, 701.

[29]

Zusi C, Rioda M, Maguolo A, et al. IGF1 and PPARG polymorphisms are associated with reduced estimated glo-merular filtration rate in a cohort of children and adoles-cents with type 1 diabetes[J]. Acta Diabetol, 2023, 60 (10): 1351-1358.

[30]

黄丽, 潘佳玥, 杨杨. IGF-1 在2 型糖尿病及2 型糖尿病肾病中的作用机制研究进展[J]. 疑难病杂志, 2024, 23(2): 253-256.

[31]

Huang L, Pan J Y, Yang Y. Advances in research on the mechanistic role of IGF-1 in type 2 diabetes mellitus and type 2 diabetic nephropathy[J]. Chin J Diff Complic Cases, 2024, 23(2): 253-256.

[32]

王艳, 王德琴, 缪娴静, 等. 糖尿病肾病危险因素病例对照研究 [J]. 实用预防医学, 2023, 30 (3): 342-344.

[33]

Wang Y, Wang D Q, Miao X J, et al. A case-control study on risk factors for diabetic nephropathy[J]. Pract Prev Med, 2023, 30(3): 342-344.

[34]

任晓红, 刘高虹. 尿 NGAL、Kim-1、L-FABP 联合检测在糖尿病肾脏病早期诊断中的价值[J]. 中国中西医结合肾病杂志, 2023, 24(12): 1096-1098.

[35]

Ren X H, Liu G H. The value of combined detection of urinary NGAL, Kim-1, and L-FABP in the early diagno-sis of diabetic kidney disease [J]. Chin J Integr Tradit West Nephrol, 2023, 24(12): 1096-1098.

[36]

赵蕾. 血清胰岛素样生长因子-1 与糖尿病肾病严重程度的相关性研究[D]. 唐山: 河北联合大学, 2015.

[37]

Zhao L. A study on the correlation between serum insulin-like growth factor-1 levels and the severity of diabetic ne-phropathy[D]. Tangshan: Hebei United University, 2015.

[38]

魏靖, 朱慧楠. 糖尿病肾病患者血清胰岛素抵抗指数、胰岛素样生长因子-1 与炎性因子表达水平的相关性[J]. 中国老年学杂志, 2019, 34(3): 546-547.

[39]

Wei J, Zhu H N. Correlation between serum insulin re-sistance index, insulin-like growth factor-1, and the ex-pression levels of inflammatory cytokines in patients with diabetic nephropathy[J]. Chin J Gerontol, 2019, 34(3): 546-547.

基金资助

*江苏省自然科学基金项目(BK20240297)

AI Summary AI Mindmap
PDF (1349KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉